1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. BIOBANKING MARKET, BY SAMPLE TYPE
5.1. Introduction
5.2. Blood Products
5.3. Human Tissues
5.4. Cell Lines
5.5. Nucleic Acids
5.6. Biological Fluids
5.7. Human Waste Products
6. BIOBANKING MARKET, BY OWNERSHIP
6.1. Introduction
6.2. Universities
6.3. National/Regional Agencies
6.4. Non-Profit Organizations
6.5. Private Organizations
7. BIOBANKING MARKET, BY APPLICATION
7.1. Introduction
7.2. Regenerative Medicine
7.3. Life Science Research
7.4. Clinical Research
8. BIOBANKING MARKET, BY END-USE
8.1. Introduction
8.2. Pharmaceutical Companies
8.3. Academic & Research Institutes
8.4. Hospitals
9. BIOBANKING MARKET, BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. United States
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. United Kingdom
9.4.2. Germany
9.4.3. France
9.4.4. Spain
9.4.5. Others
9.5. The Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Israel
9.5.4. Others
9.6. Asia Pacific
9.6.1. Japan
9.6.2. China
9.6.3. India
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
11. COMPANY PROFILES
11.1. Sapien Biosciences
11.2. Hamilton Company
11.3. UK Biobank
11.4. Apollo Hospitals
11.5. Banka Bio
11.6. Labvantage
11.7. Amgen
11.8. BioKryo
11.9. Thermo Fisher Scientific
11.10. Cureline